Skip to Main Content

Paper Details

Rapamycin inhibits prostate cancer cell growth through cyclin D1 and enhances the cytotoxic efficacy of cisplatin.
Am J Cancer Res
22
2016
Author NameAffiliation
Yong-Jie LuBarts Cancer Institute, Queen Mary University of London London
  • 1 - 1

Datasets

Release 1.2